Bio Medica Laboratories (NSE:BMLL) Cash Flow for Dividends: ₹0.0 Mil (TTM As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories Cash Flow for Dividends?

Bio Medica Laboratories NSE:BMLL +0.49% 14 Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Bio Medica Laboratories's cash flow for dividends for the six months ended in Mar. 2025 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Bio Medica Laboratories Cash Flow for Dividends Related Terms

Bio Medica Laboratories Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Cash Flow for Dividends Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
Cash Flow for Dividends
0.00 0.00 0.00

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
Cash Flow for Dividends 0.00 0.00 0.00
NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0.0 Mil mean?
Bio Medica Laboratories (NSE:BMLL) has a Cash Flow for Dividends of ₹0.0 Mil as of Mar. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Cash Flow for Dividends too high?
Bio Medica Laboratories' current Cash Flow for Dividends is ₹0.0 Mil. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Cash Flow for Dividends compare to ISRG and BDX?
Bio Medica Laboratories' Cash Flow for Dividends of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Cash Flow for Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Cash Flow for Dividends of ₹0.0 Mil. The current Cash Flow for Dividends is ₹0.0 Mil. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price